Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.261,10
-0,99%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SELLAS Life Sciences Group Inc (SLS) SELLAS Life Sciences Group Inc (SLS) Notizie

SELLAS Life Sciences Group Inc

SLS
1,32
-0,03 (-2,22%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202421:05EDGAR2Form 8-K - Current report
08/3/202422:05EDGAR2Form 8-K - Current report
05/3/202422:01EDGAR2Form 8-K - Current report
16/2/202422:05EDGAR2Form 8-K - Current report
25/1/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202412:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202423:07EDGAR2Form 8-K - Current report
05/1/202422:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202423:25EDGAR2Form 8-K - Current report
22/12/202315:05EDGAR2Form 8-K - Current report
13/12/202322:21EDGAR2Form 8-K - Current report
08/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:05EDGAR2Form 8-K - Current report
09/11/202322:07EDGAR2Form 8-K - Current report
09/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202321:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
31/10/202313:11EDGAR2Form 8-K - Current report
16/10/202314:51EDGAR2Form 8-K - Current report
13/10/202314:29EDGAR2Form 8-K - Current report
10/8/202322:12EDGAR2Form 8-K - Current report
10/8/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,36 Min: 1,29 Max: 1,37
Chiusura: 1,35

La tua Cronologia

NASDAQ
SLS
SELLAS Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network